Trial · NCT01718483
Results by group92
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 92
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in the Number of Binge Days Per Week at Visit 8 (Weeks 11-12) | PLACEBO | -2.51 | Standard Error 0.125 | Binge days per week | |
| Change From Baseline in the Number of Binge Days Per Week at Visit 8 (Weeks 11-12) | SPD489 | -3.87 | Standard Error 0.124 | Binge days per week | |
| Percentage of Participants With Improvement on Clinical Global Impression-Improvement (CGI-I) Scores | PLACEBO | 47.3 | 95% Confidence Interval 40.1 to 54.5 | percentage of participants | |
| Percentage of Participants With Improvement on Clinical Global Impression-Improvement (CGI-I) Scores | SPD489 | 82.1 | 95% Confidence Interval 76.7 to 87.6 | percentage of participants | |
| Percentage of Participants With a 4-Week Cessation From Binge Eating | PLACEBO | 14.1 | 95% Confidence Interval 9.1 to 19.2 | percentage of participants | |
| Percentage of Participants With a 4-Week Cessation From Binge Eating | SPD489 | 40.0 | 95% Confidence Interval 33.0 to 47.0 | percentage of participants | |
| Percent Change From Baseline in Body Weight at Week 12 | PLACEBO | 0.11 | Standard Error 0.295 | percent change | |
| Percent Change From Baseline in Body Weight at Week 12 | SPD489 | -6.25 | Standard Error 0.292 | percent change | |
| Change From Baseline in Yale-Brown Obsessive Compulsive Scale Modified for Binge Eating (Y-BOCS-BE) Total Score at Week 12 | PLACEBO | -8.28 | Standard Error 0.550 | units on a scale | |
| Change From Baseline in Yale-Brown Obsessive Compulsive Scale Modified for Binge Eating (Y-BOCS-BE) Total Score at Week 12 | SPD489 | -15.68 | Standard Error 0.546 | units on a scale | |
| Change From Baseline in Fasting Triglyceride Levels at Up to 12 Weeks | PLACEBO | 0.122 | Standard Error 0.0405 | millimole per liter (mmol/L) | |
| Change From Baseline in Fasting Triglyceride Levels at Up to 12 Weeks | SPD489 | -0.077 | Standard Error 0.0393 | millimole per liter (mmol/L) | |
| Change From Baseline In Fasting Total Cholesterol Levels at Up to 12 Weeks | PLACEBO | -0.094 | Standard Error 0.0435 | mmol/L | |
| Change From Baseline In Fasting Total Cholesterol Levels at Up to 12 Weeks | SPD489 | -0.305 | Standard Error 0.0422 | mmol/L | |
| Change From Baseline in Hemoglobin A1c Levels at Up to 12 Weeks | PLACEBO | 0.01 | Standard Error 0.016 | Percent hemoglobin | |
| Change From Baseline in Hemoglobin A1c Levels at Up to 12 Weeks | SPD489 | -0.02 | Standard Error 0.015 | Percent hemoglobin | |
| Binge Eating Response | PLACEBO | 1-week cessation | 26.6 | percentage of participants | |
| Binge Eating Response | SPD489 | 1-week cessation | 47.1 | percentage of participants | |
| Binge Eating Response | PLACEBO | Marked Reduction | 15.2 | percentage of participants | |
| Binge Eating Response | SPD489 | Marked Reduction | 31.6 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01718483/results